Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AE58054 drug-drug interaction study with midazolam and dextromethorphan in healthy young men
NL-OMON34119Active, not recruiting
- Sponsor
- Lundbeck
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Idalopirdine in schizophrenia and Alzheimer's disease (AD), sponsored by Lundbeck. Primary endpoints: Effect of multiple doses of Lu AE58054 on midazolam pharmacokinetics and Effect of multiple doses of Lu AE58054 on dextromethorphan pharmacokinetics. Started Sep 2010; status: active, not recruiting.
02
Drugs
Idalopirdine
03
Conditions
schizophreniaAlzheimer's disease (AD)
Beyond the preview
Go deeper on NL-OMON34119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34119.